SPECT/CT淋巴显像在新辅助化疗后淋巴结阳性乳腺癌中准确示踪标记淋巴结与前哨淋巴结
本研究纳入62例经活检证实腋窝淋巴结转移并接受新辅助化疗的乳腺癌女性患者,术前行99mTc-纳米胶体注射及SPECT/CT淋巴显像,评估其对靶向腋窝清扫的定位作用。结果显示标记淋巴结为前哨淋巴结者54例(88.5%),靶向腋窝清扫总体假阴性率为3.33%,中位随访29个月无腋窝复发。结论认为SPECT/CT淋巴显像可准确示踪新辅助化疗后的标记淋巴结和前哨淋巴结。
要点
- 62例淋巴结阳性乳腺癌患者新辅助化疗后行SPECT/CT淋巴显像,标记淋巴结为前哨淋巴结者占88.5%。
- 靶向腋窝清扫总体假阴性率为3.33%,平均随访29个月无腋窝复发。
- SPECT/CT在所有患者中均正确示踪了标记淋巴结。
核心结论
- SPECT/CT淋巴显像可在淋巴结阳性乳腺癌患者新辅助化疗后准确示踪标记淋巴结和前哨淋巴结。
研究设计与样本
- 本研究纳入62例经活检证实腋窝淋巴结转移并接受新辅助化疗的女性乳腺癌患者,化疗前在取样淋巴结放置金属标记夹,手术当日行乳晕周围皮内注射99mTc-纳米胶体后行SPECT/CT淋巴显像,随后行乳腺手术联合靶向腋窝清扫。
主要发现
- 入组患者为T1-4、N1-2期,所有患者均行前哨淋巴结活检。
- 标记淋巴结为前哨淋巴结者54例(88.5%),3例(4.9%)标记夹位于非前哨淋巴结。
- 4例患者标记夹在SPECT/CT图像上不可见,术中未找到淋巴结。
- SPECT/CT在所有患者中均正确示踪了标记淋巴结。
- 靶向腋窝清扫总体假阴性率为3.33%,平均随访29个月,无腋窝复发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to evaluate the impact of SPECT/CT lymphoscintigraphy on targeted axillary dissection (TAD) in node-positive breast cancer (BC) patients who had undergone neoadjuvant chemotherapy (NAC). METHODS: Sixty-two female BC patients with biopsy-confirmed axillary nodal metastases underwent NAC, followed by breast surgery with TAD. A metallic clip was placed in the sampled LN before NAC. On the day of surgery, a periareolar intradermal 99m Tc-nanocolloid injection was administered, followed by SPECT/CT lymphoscintigraphy. The clipped nodes were localized on CT images, assessed for 99m Tc uptake before surgery, and confirmed during the procedure. RESULTS: T1-4, N1-2 patients were enrolled in the study. All patients underwent sentinel lymph node (SLN) biopsy. The clipped node was the SLN in 54 (88.5%) patients. In 3 patients (4.9%), a clip was found in a nonsentinel lymph node. In 4 patients, the clips were not visible on SPECT/CT images, and lymph nodes were not found during the procedure. SPECT/CT correctly localized the clipped lymph node in all patients. The overall false-negative rate for TAD was 3.33%. The mean follow-up duration was 29 months, and there were no axillary recurrences. CONCLUSIONS: SPECT/CT lymphoscintigraphy can accurately localize clipped nodes and SLNs after NAC in patients with node-positive BC.
引用
- Dilege E, Celik B, Falay O, et al. SPECT/CT Lymphoscintigraphy Accurately Localizes Clipped and Sentinel Nodes After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer. Clin Nucl Med. 2023. PMID: 37075247. doi:10.1097/RLU.0000000000004669
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。